Securitization as a means to pay for cell and gene therapies for orphan diseases: a simulation study.

Lu JM, Cherla AJ, Carter AW, Mossialos EA

Open source

DOI
10.1038/s41434-026-00604-6
Published
2026 Mar
Container
Gene therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41434-026-00604-6,
  title = {Securitization as a means to pay for cell and gene therapies for orphan diseases: a simulation study.},
  author = {Lu JM and Cherla AJ and Carter AW and Mossialos EA},
  year = {2026},
  journal = {Gene therapy},
  doi = {10.1038/s41434-026-00604-6},
  url = {https://doi.org/10.1038/s41434-026-00604-6}
}

RIS

TY  - JOUR
TI  - Securitization as a means to pay for cell and gene therapies for orphan diseases: a simulation study.
AU  - Lu JM
AU  - Cherla AJ
AU  - Carter AW
AU  - Mossialos EA
PY  - 2026
JO  - Gene therapy
DO  - 10.1038/s41434-026-00604-6
UR  - https://doi.org/10.1038/s41434-026-00604-6
ER  - 

APA

JM, L., AJ, C., AW, C., & EA, M. (2026). Securitization as a means to pay for cell and gene therapies for orphan diseases: a simulation study.. Gene therapy. https://doi.org/10.1038/s41434-026-00604-6

Source records